%0 Case Reports
%T Hematopoietic stem cell transplantation from an infected SARS-CoV2 haploidentical donor: A case report.
%A Chen X
%A Ma Q
%A Pang A
%A Yang D
%A Liang C
%A Liu Q
%A Liu X
%A Zheng X
%A Jiang E
%A Han M
%A Feng S
%J IDCases
%V 34
%N 0
%D 2023
%M 37928818
暂无%R 10.1016/j.idcr.2023.e01913
%X <B>UNASSIGNED: </B>We report a case of an adult hematopoietic stem cell donor who developed active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the donation of stem cells, the final transplantation was successfully completed without SARS-CoV-2 transmission.<BR><B>UNASSIGNED: </B>We report on a 34-year-old female diagnosed with acute lymphoblastic leukemia who underwent hemiploid hematopoietic stem cell transplantation (HSCT). Both patient and donor received three doses of inactivated SARS-CoV-2 vaccine before transplantation. PB-HSC was collected by the donor during the process of infection with SARS-CoV-2 (mild), and the patient did not show symptoms related to SARS-CoV-2 after transplantation. Nucleic acid and antigen were negative in regular tests.<BR><B>UNASSIGNED: </B>In the context of the current Omicron epidemic and high vaccination rate in the population, it is feasible to receive PB-HSC from infected donors even for immunocompromised patients. This also provides some references for our later donor selection.